Table 1 Baseline characteristics
| Â | Values |
|---|---|
Age (years) | 61.6 ± 12.1 |
Sex | |
 Male | 46 (50.0%) |
Duration of HD (years) | 8.3 ± 4.9 |
Cause of ESRD | |
 DM | 46 (50.0%) |
 HTN | 21 (22.8%) |
 Primary GN | 8 (8.7%) |
 ADPKD | 2 (2.2%) |
 Others | 8 (8.7%) |
 Unknown | 5 (5.4%) |
Medical history | |
 DM | 46 (50.0%) |
 HTN | 86 (93.5%) |
 CVD | 22 (23.9%) |
 CHF | 12 (13.0%) |
 VHD | 7 (7.6%) |
 CAOD | 11 (12.0%) |
 PAOD | 4 (4.3%) |
 Arrhythmia | 6 (6.5%) |
 CVA | 16 (17.4%) |
 Bleeding a | 10 (10.9%) |
 Chronic liver disease | 9 (9.8%) |
 Malignancy | 17 (18.5%) |
 Thyroid illness | 8 (8.7%) |
Medication history | |
 Antiplatelet agents | 75 (81.5%) |
 Anticoagulants | 4 (4.3%) |
 Antihypertensive agents | 86 (93.5%) |
 Thyroid hormones | 5 (5.4%) |
Surgical history | |
 Parathyroidectomy | 4 (4.3%) |
 Heart operation | 7 (7.6%) |
 Kidney transplantation | 9 (9.8%) |
 Solid organ transplantation b | 3 (3.3%) |